Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
作者信息
Beach Renée A
机构信息
Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Canada.
出版信息
Dermatol Ther. 2018 Nov;31(6):e12707. doi: 10.1111/dth.12707. Epub 2018 Sep 24.
Abstract
摘要
相似文献
1
Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.口服米诺地尔治疗雄激素性脱发和牵引性脱发的病例系列：耐受性及口服治疗的五个C因素
Dermatol Ther. 2018 Nov;31(6):e12707. doi: 10.1111/dth.12707. Epub 2018 Sep 24.
2
Multi-therapies in androgenetic alopecia: review and clinical experiences.雄激素性脱发的多种治疗方法：综述与临床经验
Dermatol Ther. 2016 Nov;29(6):424-432. doi: 10.1111/dth.12390. Epub 2016 Jul 18.
3
Oral minoxidil treatment for hair loss: A review of efficacy and safety.口服米诺地尔治疗脱发：疗效与安全性综述
J Am Acad Dermatol. 2021 Mar;84(3):737-746. doi: 10.1016/j.jaad.2020.06.1009. Epub 2020 Jul 2.
4
Use of topical minoxidil therapy for androgenetic alopecia in women.外用米诺地尔治疗女性雄激素性脱发
Int J Dermatol. 1993 Oct;32(10):758-62. doi: 10.1111/j.1365-4362.1993.tb02755.x.
5
Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data.应用远程医疗数据回顾性研究外用非那雄胺/米诺地尔治疗男性雄激素性脱发的患者报告结局。
J Cosmet Dermatol. 2024 Sep;23(9):2956-2963. doi: 10.1111/jocd.16360. Epub 2024 May 7.
6
Controversies in the treatment of androgenetic alopecia: The history of finasteride.雄激素性脱发治疗的争议：非那雄胺的历史。
Dermatol Ther. 2019 Mar;32(2):e12647. doi: 10.1111/dth.12647. Epub 2018 Sep 25.
7
Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.局部用米诺地尔与局部用阿法骨化醇治疗女性雄激素性脱发的疗效与安全性比较。
J Dtsch Dermatol Ges. 2007 May;5(5):391-5. doi: 10.1111/j.1610-0387.2007.06295.x.
8
Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls.口服米诺地尔与螺内酯联合治疗青春期女性雄激素性脱发
J Am Acad Dermatol. 2021 Jun;84(6):1689-1691. doi: 10.1016/j.jaad.2020.10.097. Epub 2021 Jan 9.
9
Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.5%米诺地尔与5%米诺地尔联合0.01%维甲酸治疗男性型脱发的疗效：一项随机、双盲、对照临床试验
Am J Clin Dermatol. 2007;8(5):285-90. doi: 10.2165/00128071-200708050-00003.
10
Relation between treatment efficacy and cumulative dose of 3% topical minoxidil in male pattern baldness.3%外用米诺地尔治疗男性型秃发的疗效与累积剂量之间的关系
J Am Acad Dermatol. 2012 Jan;66(1):e10-2. doi: 10.1016/j.jaad.2010.10.008.
引用本文的文献
1
Efficacy and safety of oral minoxidil in the treatment of alopecia: a single-arm rate meta-analysis and systematic review.口服米诺地尔治疗脱发的疗效与安全性：单臂率Meta分析及系统评价
Front Pharmacol. 2025 Jun 3;16:1556705. doi: 10.3389/fphar.2025.1556705. eCollection 2025.
2
The Role of Patient- and Drug-Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System.患者及药物相关因素在口服米诺地尔与心包积液中的作用：来自美国食品药品监督管理局不良事件报告系统的数据分析
J Cosmet Dermatol. 2025 Feb;24(2):e16732. doi: 10.1111/jocd.16732. Epub 2024 Dec 16.
3
Low-Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions.低剂量口服米诺地尔及其相关不良事件：对美国食品药品监督管理局不良事件报告系统（FAERS）的分析，重点关注心包积液。
J Cosmet Dermatol. 2025 Jan;24(1):e16574. doi: 10.1111/jocd.16574. Epub 2024 Sep 26.
4
Low-dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-based Consensus Statement of Indian Experts.低剂量口服米诺地尔治疗脱发：印度专家基于证据和经验的共识声明
Int J Trichology. 2023 May-Jun;15(3):91-97. doi: 10.4103/ijt.ijt_70_23. Epub 2023 Dec 1.
5
Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.雄激素性脱发的治疗：当前指南与未满足的需求。
Clin Cosmet Investig Dermatol. 2023 May 31;16:1387-1406. doi: 10.2147/CCID.S385861. eCollection 2023.
6
Relevant Dermatoses Among U.S. Military Service Members: An Operational Review of Management Strategies and Telemedicine Utilization.美国军人中的相关皮肤病：管理策略与远程医疗利用的业务综述
Cureus. 2023 Jan 2;15(1):e33274. doi: 10.7759/cureus.33274. eCollection 2023 Jan.
7
Role of Oral Minoxidil in Patterned Hair Loss.口服米诺地尔在雄激素性脱发中的作用。
Indian Dermatol Online J. 2022 Oct 12;13(6):729-733. doi: 10.4103/idoj.idoj_246_22. eCollection 2022 Nov-Dec.
8
Treatment of traction alopecia with oral minoxidil.口服米诺地尔治疗牵引性脱发。
JAAD Case Rep. 2022 Apr 1;23:112-113. doi: 10.1016/j.jdcr.2022.03.023. eCollection 2022 May.
9
Oral minoxidil use in androgenetic alopecia and telogen effluvium.米诺地尔口服制剂在雄激素性脱发和休止期脱发中的应用。
Arch Dermatol Res. 2023 Mar;315(2):201-205. doi: 10.1007/s00403-022-02331-5. Epub 2022 Mar 4.
10
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.雄激素性脱发的治疗选择：疗效、副作用、依从性、经济考虑因素和伦理问题。
J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6.
本文引用的文献
1
Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study.口服米诺地尔治疗慢性休止期脱发：一项回顾性研究。
F1000Res. 2017 Sep 6;6:1650. doi: 10.12688/f1000research.11775.1. eCollection 2017.
2
Treatment of monilethrix with oral minoxidil.口服米诺地尔治疗念珠状发。
JAAD Case Rep. 2016 May 26;2(3):212-5. doi: 10.1016/j.jdcr.2016.02.011. eCollection 2016 May.
3
Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil.低剂量口服米诺地尔治疗永久性化疗所致脱发
Australas J Dermatol. 2016 Nov;57(4):e130-e132. doi: 10.1111/ajd.12350. Epub 2015 May 13.
4
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension.社区高血压管理临床实践指南：美国高血压学会和国际高血压学会声明
J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26. doi: 10.1111/jch.12237. Epub 2013 Dec 17.
5
Female pattern hair loss: current treatment concepts.女性型脱发：当前的治疗理念
Clin Interv Aging. 2007;2(2):189-99.
6
Traction alopecia: 2% topical minoxidil shows promise. Report of two cases.牵引性脱发：2%外用米诺地尔显示出前景。两例报告。
J Eur Acad Dermatol Venereol. 2007 Mar;21(3):433-4. doi: 10.1111/j.1468-3083.2006.01933.x.
Zotero 插件